Senate Bill S8364

2025-2026 Legislative Session

Relates to the administration of reversible progestin-only contraceptive injections

download bill text pdf

Sponsored By

Current Bill Status - In Senate Committee Rules Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

2025-S8364 (ACTIVE) - Details

See Assembly Version of this Bill:
A8664
Current Committee:
Senate Rules
Law Section:
Education Law
Laws Affected:
Amd §§6802 & 6801, Ed L

2025-S8364 (ACTIVE) - Summary

Relates to the administration of reversible progestin-only contraceptive injections; provides that no pharmacist shall administer reversible progestin-only contraceptive injections without receiving training satisfactory to the commissioner of education and the commissioner of health.

2025-S8364 (ACTIVE) - Sponsor Memo

2025-S8364 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8364
 
                        2025-2026 Regular Sessions
 
                             I N  S E N A T E
 
                               June 5, 2025
                                ___________
 
 Introduced  by  Sen.  WEBB  --  read twice and ordered printed, and when
   printed to be committed to the Committee on Rules
 
 AN ACT to amend the education law, in relation to the administration  of
   reversible progestin-only contraceptive injections
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 22 of section 6802  of  the  education  law  is
 amended by adding a new paragraph c to read as follows:
   C.  THE  ADMINISTRATION  OF  A REVERSIBLE PROGESTIN-ONLY CONTRACEPTIVE
 INJECTION  APPROVED  BY  THE  U.S.  FOOD  AND  DRUG  ADMINISTRATION,  AS
 PRESCRIBED  OR ORDERED BY A LICENSED PRESCRIBER, ACTING WITHIN THE SCOPE
 OF THEIR PRACTICE IN THIS  STATE  AND  IN  ACCORDANCE  WITH  REGULATIONS
 PROMULGATED BY THE COMMISSIONER, PROVIDED THAT:
   (1)  SUCH ADMINISTRATION IS CONDUCTED PURSUANT TO A VALID PATIENT-SPE-
 CIFIC PRESCRIPTION OR PATIENT-SPECIFIC ORDER.
   (2) THE PHARMACIST SHALL  NOTIFY  THE  LICENSED  PRESCRIBER  THAT  THE
 ADMINISTRATION IS COMPLETE WITHIN FIVE DAYS AND SHALL CONVEY SUCH INFOR-
 MATION  TO THE PRESCRIBER BY MAKING AN ENTRY INTO AN INTEROPERABLE ELEC-
 TRONIC MEDICAL RECORDS SYSTEM, AN ELECTRONIC PRESCRIBING TECHNOLOGY OR A
 PHARMACY RECORD, OR BY USING FACSIMILE, ELECTRONIC TRANSMISSION OR OTHER
 ELECTRONIC MEANS.  IF AN ELECTRONIC MEANS DESCRIBED IN THIS SUBPARAGRAPH
 IS NOT AVAILABLE TO THE PHARMACIST AT THE  TIME  OF  COMMUNICATION,  THE
 PHARMACIST  OR  PHARMACIST'S DESIGNEE MAY COMMUNICATE THE INFORMATION BY
 TELEPHONE.  NOTIFICATION SHALL ALSO BE REQUIRED IF A  PATIENT  DOES  NOT
 RECEIVE AN ADMINISTRATION OR IF THE PATIENT EXPERIENCES ANY SIDE EFFECTS
 OR  ADVERSE  REACTIONS  TO THE MEDICATIONS. ADMINISTRATION IN A PHARMACY
 SHALL NOT COMMENCE UNTIL AFTER THE  PATIENT  HAS  RECEIVED  THE  INITIAL
 INJECTION  AND  IS  CONSIDERED ELIGIBLE FOR MAINTENANCE TREATMENT BY THE
 LICENSED PRESCRIBER.
   (3) SUCH PRESCRIPTION MAY BE SUBJECT TO  REASSESSMENT  AT  APPROPRIATE
 INTERVALS, AS DETERMINED BY THE LICENSED PRESCRIBER.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD13237-02-5
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.